Risk of infection by the consumption of liver of chickens inoculated with low doses of Toxocara canis eggs.

Experimental studies and registries of cases of human toxocariasis have shown that the consumption of raw or undercooked offal of the paratenic host of Toxocara canis may pose a risk of infection. Thus, we evaluated the risk of infection due to the consumption of liver of chickens inoculated with different doses of embryonated T. canis eggs. Doses were 5-100 times smaller than the ones previously employed in this type of study. Groups of five chickens were inoculated with 5000 (control), 1000, 500, 300 or 50 eggs of T. canis, and at 72 h post-inoculation, the liver of each bird was consumed by a BALB/c receptor mouse. Forty-eight hours after consumption, we examined the organs and carcasses of the mice for larvae of T. canis. All mice were positive for larvae, except the group that consumed the chicken liver inoculated with 50 eggs. This group contained only one positive mouse, in which the larva was lodged in the brain. In mice that consumed livers of chickens inoculated with ≥300 eggs, larvae concentration was primarily in the liver and lungs, characterizing the initial phase of infection. We conclude that the consumption of raw poultry liver, under the studied conditions, poses a risk of infection even with a low number of infected T. canis eggs.

Evaluation of the immunosuppressive effect of cyclophosphamide and dexamethasone in mice with visceral toxocariasis.

Visceral toxocariasis is a serious public health problem with a cosmopolitan distribution. Children are susceptible due to their immature immune system and high risks of infection. Nevertheless, the few completed studies about immunosuppression have had controversial results. To evaluate the effect of two immunosuppressive drugs on the larval burden of Toxocara canis, four groups of ten Swiss strain mice each were inoculated on day 0 with 1,200 embryonated T. canis eggs. Fifteen days before the experimental infection, group 1 (control) was treated via intraperitoneal injection (IP) with sterile distilled water and groups 2 and 3 were treated with dexamethasone (DEX) at 1 and 5 mg/kg/day, respectively. Additionally, group 4 was treated IP with cyclophosphamide (CY) at 50 mg/kg at two times per week for 2 weeks. Sixty days following infection, the mice were euthanised to recover the larvae by means of the tissue digestion technique. The levels of antibodies detected by indirect ELISA were not associated with the larval burden. Administration of CY (50 mg/kg) and DEX (5 mg/kg) resulted in an increase of the larval burden of 162.1% and 50.8%, respectively, in relation to the control group. These two treatments, especially CY (50 mg/kg), promoted immunosuppression and the establishment of a significant larval burden, supporting its further utilisation in studies related to immunosuppression in visceral toxocariasis.